Participants will receive subcutaneous (SC) golimumab, where doses will be based on weight and/or body surface area.
Other Name: SIMPONI
Rady Children's Hospital
San Diego, California, 92123
Janssen Research & Development, LLC Clinical Trial
Janssen Research & Development, LLC
Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.